Wilson Sonsini Goodrich & Rosati advised Denali Therapeutics on the deal, while Davis Polk advised the representatives of the several underwriters.Denali Therapeutics, a biopharmaceutical company developing…
Denali Therapeutics’ $316 Million Public Offering

























